Camille Cash
Plastic Surgery · Houston, TXNPI 1013967660
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $156,354 of the $212,464 with a category attached, or 73.6%. AbbVie accounts for 92.1% of it on its own, with 18 other manufacturers making up the rest. Among plastic surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 325 payments — averaging $653.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$196K
- Motiva USA, LLC$4K
- Galderma Laboratories, L.p.$4K
- Solta Medical, A Division Of Bausch Health US, LLC$3K
- Sientra, Inc.$2K
- Merz North America, Inc.$1K
- plus $3K from 13 others
Across 5 payments — averaging $2879.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$14K
What the payments were for
- Consulting fees$156,35474%
- Speaking & faculty fees$25,67512%
- Travel & lodging$13,7096%
- Food & beverage$13,2806%
- Gifts$2,4641%
- Other$9820%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 224 | $195,751 |
| Motiva USA, LLC | 13 | $4,393 |
| Galderma Laboratories, L.p. | 31 | $4,148 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $3,000 |
| Sientra, Inc. | 22 | $1,567 |
| Merz North America, Inc. | 5 | $1,004 |
| Surgical Innovation Associates, Inc. | 1 | $656 |
| Mentor Worldwide LLC | 8 | $572 |
| Musculoskeletal Transplant Foundation Inc. | 6 | $561 |
| Integra Lifesciences Corporation | 1 | $326 |
| Coopersurgical, Inc. | 1 | $101 |
| Revance Therapeutics, Inc. | 3 | $100 |
| Davol Inc. | 1 | $97 |
| Pacira Pharmaceuticals Incorporated | 2 | $74 |
| Acelrx Pharmaceuticals, Inc. | 2 | $30 |
| Bard Peripheral Vascular, Inc. | 1 | $28 |
| Medtronic | 1 | $23 |
| Organogenesis Inc. | 1 | $19 |
| Tepha Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NATRELLE SALINE-FILLED BREAST IMPLANTS$88,048
- BOTOX$57,790
- REVOLVE$31,209
- ALLODERM$12,489
- STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS$12,339
- KYBELLA$11,244
- BOTOX COSMETIC$7,324
- Motiva Implant Matrix$3,931
- NATRELLE$2,377
- DuraSorb Monofilament Mesh$982
- SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT$811
- MENTOR MemoryGel Resterilizable Gel Sizer$406
- ARTOURA Breast Tissue Expander$145
- Laparoscopic Instruments$101
How this compares
$212,464 in reported general payments places this provider in the 95th percentile of 337 plastic surgery providers in Texas.
Other plastic surgery in Houston
- Younghoon ChoHouston$1.2M
- David AdelmanHouston$405K
- Warren EllsworthHouston$284K
- Robert YarishHouston$180K
- Alexander MericliHouston$125K
- Kristy HamiltonHouston$70K
- Jenny NguyenHouston$45K
- Patrick HsuHouston$34K
- Anthony EchoHouston$27K
- Matthew GreivesHouston$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.